Prostate biopsy

$3.84 Bn Biopsy Devices Market, Size, Global Forecast Report 2024-2030 Featuring Cardinal Health, Hologic, Danaher, BD and Co, Boston Scientific, Medtronic, Olympus, and CONMED - ResearchAndMarkets.com

Retrieved on: 
Martedì, Aprile 23, 2024
Health, Oncology, Medical Devices, Insight, Cancer, WHO, Magnetic resonance imaging, World Health Organization, Prostate biopsy, Woman, Research, Trauma, Traction, Lung biopsy, Needle, Attention, Disease, Biopsy, Infection, Diagnosis, Breast biopsy, Liver biopsy, Medical imaging

The increasing occurrence of cancers globally drives growth within the biopsy devices market.

Key Points: 
  • The increasing occurrence of cancers globally drives growth within the biopsy devices market.
  • Innovations like Vacora, Finesse Ultra Breast Biopsy System, and Celero VAB gadgets will bolster the boom trajectory of the biopsy devices market.
  • The biopsy devices market is segmented based on application into Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Gastroenterology Biopsy, and Others.
  • Due to their superior imaging technologies and specialized information, diagnostic and imaging facilities are among the segments gaining traction within the global biopsy devices market.

Biopsy Devices Market Predicted to Achieve Striking Growth of USD 3.96 Billion with Healthy CAGR of 7.3% by 2029, Size, Share, Trends, Demand and Competitive Analysis

Retrieved on: 
Martedì, Marzo 7, 2023
Sentinel, Laparoscopy, Diagnosis, Needle, Laboratory, DNA, Lymph node, Infection, Liquid biopsy, Breast cancer, Jamshidi needle, Nucleic acid thermodynamics, Saliva, Skin cancer, Magnetic resonance, Ambulatory Surgery Center Association, EVS, Archives of Pathology & Laboratory Medicine, Consumables, Prostate, Research, Disposable product, Midsayap Diagnostic Center and Hospital, Cancer, Academic institution, Prostate cancer, Prostate biopsy, Recurrence, Neoplasm, System, Lung cancer, National Virus Reference Laboratory, MRI, Inflammation, Liver cancer, Wilford Hall Ambulatory Surgical Center, Skeletal muscle, Biomarker, Seminal vesicles, Fine-needle aspiration, Chinese, Stereotactic surgery, Medical imaging, Trans, Hospital, Biopsy, Hysterectomy, Disease, Human factors and ergonomics, Country, Hysteroscopy

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...

Key Points: 
  • To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...
    North America Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-biopsy-de...
    Europe Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Mri-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country https://www.databridgemarketresearch.com/reports/europe-biopsy-devices-m...
    Asia-Pacific Biopsy Devices Market By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/asia-pacific-biopsy-dev...
    Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) https://www.databridgemarketresearch.com/reports/global-breast-biopsy-de...
    North America Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems and Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization and Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy and Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Other), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-breast-bi...
    Europe Breast Biopsy Devices Market , By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), Type (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy, Other Biomarkers), Guidance (Image-Guided Biopsy, Liquid Biopsy, Other Guidance Techniques), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), Country https://www.databridgemarketresearch.com/reports/europe-breast-biopsy-de...
    Asia-Pacific Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other), Country https://www.databridgemarketresearch.com/reports/asia-pacific-breast-bio...
    Smart Biopsy Devices Market , By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers) Country https://www.databridgemarketresearch.com/reports/global-smart-biopsy-dev...
    Vacuum Assisted Biopsy Devices Market , By Product (Vacuum-assisted Biopsy Systems, Vacuum-assisted Biopsy Needles), Type (9-12G, 12G), Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, Others), Applications (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others) https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Endobronchial Ultrasound Biopsy Devices Market , By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Trans bronchial Aspiration Needles, Spray Catheters, Others), Application (Cancer Diagnosis, Infection Diagnosis, Others), Country https://www.databridgemarketresearch.com/reports/global-endobronchial-ul...
    Liquid Biopsy Market , By Sampling Type (Blood Sampling Liquid Biopsy, Urine Sampling Liquid Biopsy and Saliva and Other Tissue Fluids Sampling Liquid Biopsy), Products and Service (Assays Kits, Instruments and Services), Circulating Biomarker (Circulating Tumour Cells, Circulating Tumour DNA (CTDNA), Cell-Free DNA, Extracellular Vesicles (EVS) and Other Circulating Biomarkers), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring and Recurrence Monitoring), Application (Cancer Applications and Non-Cancer Applications), End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centres and Other End Users) https://www.databridgemarketresearch.com/reports/global-liquid-biopsy-ma...
    Breast Cancer Liquid Biopsy Market , By Product (Consumables, Kits), Circulating Biomarkers (Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), ctRNA, Circulating Tumor Cells (CTCs), cfRNA, Others), End Users (Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories), Country https://www.databridgemarketresearch.com/reports/global-breast-cancer-li...
    Core Needle Biopsy Market , By Type (Full-Automated Core Needle Biopsy Device and Semi-Automated Core Needle Biopsy Device), Applications (Hospitals, Clinics and Others), Disease (Lung Cancer, Liver Cancer, Breast Cancer and Prostate Cancer), Range (14G- 18G, 18G), Distribution Channel (Direct Sales and Distributor), Country https://www.databridgemarketresearch.com/reports/global-core-needle-biop...
    Image-Guided Biopsy Market , By Technology (X- Ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country https://www.databridgemarketresearch.com/reports/global-image-guided-bio...
    Vacuum-Assisted Biopsy Market By Guiding Technique (Stereotactic Vacuum Assist Biopsy System and Image Guided Vacuum Assist Biopsy System), Type (9-12G, 12G), Applications (Hospitals, Academic and Research Institutes and Diagnostics and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Needle Biopsy Market , By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales), Country https://www.databridgemarketresearch.com/reports/global-needle-biopsy-ma...
    Biopsy Forceps Market , By Type (Rigid Biopsy Forceps, Flexible Biopsy Forceps), Product Type (Cupped Jaws Biopsy Forceps, Oval Ring Jaws Biopsy Forceps, Radial Jaw Biopsy Forceps, Others), Usability (Disposable Biopsy Forceps, Reusable Biopsy Forceps), Application (Laparoscopy, Hysterectomy, Hysteroscopy, Others), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-forceps-m...
    Biopsy Guns and Needles Market , By Product Type (Disposable, Reusable), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-guns-and-...

Global Biopsy Devices Market Report to 2027: Featuring Boston Scientific, Cardinal Health, Medtronic, BD, Cook and Devisor Medic Among Others - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Marzo 3, 2023
Health, Oncology, Medical Devices, Needle, Cancer, Prevalence, Breast cancer, World Health Organization, Classification, 3rd millennium, FDA, Woman, Midsayap Diagnostic Center and Hospital, Incidence, Bone marrow, Breast biopsy, Patient, Hospital, WHO, Skin biopsy, Lung cancer, Infection, Disease, Growth, Wilford Hall Ambulatory Surgical Center, American Cancer Society, Prostate biopsy, Neoplasm, Competitive landscape, Partnership, Ageing, Semiconductor, Medical imaging, Video game, Medical device, Biopsy, Others, Geography, Forceps

Therefore, the increasing prevalence of breast cancer boosts the biopsy devices demand, which surges the biopsy devices overall market forward over the forecast period (2022-2027).

Key Points: 
  • Therefore, the increasing prevalence of breast cancer boosts the biopsy devices demand, which surges the biopsy devices overall market forward over the forecast period (2022-2027).
  • Therefore, rising geriatric population increases the demand for biopsy devices, this surge the biopsy devices overall market forward over the forecast period (2022-2027).
  • Therefore, the aforementioned factors boosts the biopsy devices demand, which surge the growth of overall biopsy devices market during the forecast period from 2022-2027.
  • Therefore, rising incidence of lung cancer increases the demand for biopsy devices thereby, propelling the growth of biopsy devices overall market.

BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS

Retrieved on: 
Martedì, Maggio 10, 2022
AUA, National Comprehensive Cancer Network, Population, Medicare, Prostate biopsy, ISO, EPI, MRI, NASDAQ, Exosome, Clinical research, Travel, NCCN, Physician, Patient, Convention center, Cancer, Diagnosis, PCA, Baltimore Orioles, American Cancer Society, Urology, Bio-Techne, PSA, Association, Biomarker, Prostate, Prostate cancer, Disease, CLIA, Risk assessment, Conference, Genomics, National Baseball Hall of Fame and Museum, Medical director, RNA transfection, Biopsy, Awareness, Man, Risk, Medical device, Medical imaging, Cal

MINNEAPOLIS, May 10, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, will have a major scientific presence at the annual American Urological Association Conference (AUA) taking place May 13-16 in New Orleans, LA.

Key Points: 
  • MINNEAPOLIS, May 10, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, will have a major scientific presence at the annual American Urological Association Conference (AUA) taking place May 13-16 in New Orleans, LA.
  • A Combined Biomarker/mpMRI Approach Provides Enhanced Clinical Information Prior to Prostate Biopsy by Dr. Alexander Kretschmer et al.
  • "Cal is a great example of the powerful role our ExoDx Prostate test plays in the prostate cancer journey.
  • Currently, nearly 3.6 million American men are living with the disease only slightly less than the population of Los Angeles.

New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer

Retrieved on: 
Martedì, Luglio 27, 2021
Health, Genetics, Science, Research, Oncology, Clinical medicine, Medical specialties, Medicine, Prostate cancer, Histopathology, Biopsy, Prostate biopsy, Cancer, Prostate, Prostate cancer screening, Prostate-specific antigen, Decipher Prostate, Veracyte, DECIPHER PROSTATE, VERACYTE

(Nasdaq: VCYT) today announced new data suggesting the Decipher Prostate Biopsy genomic classifier (GC) may help guide treatment decisions for prostate cancer patients who are candidates for active surveillance (AS).

Key Points: 
  • (Nasdaq: VCYT) today announced new data suggesting the Decipher Prostate Biopsy genomic classifier (GC) may help guide treatment decisions for prostate cancer patients who are candidates for active surveillance (AS).
  • Between February 2015 and October 2019, 855 MUSIC registry participants with newly diagnosed prostate cancer underwent testing with the Decipher Prostate Biopsy test.
  • Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) is a 22-gene, whole-transcriptome-developed genomic test intended to help inform treatment decisions for men with localized prostate cancer at initial diagnosis and after surgical removal of the prostate.
  • The companys tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development.

NeoDynamics receives first German order of pulse biopsy system NeoNavia

Retrieved on: 
Venerdì, Luglio 9, 2021
Clinical medicine, Medicine, Medical specialties, Biopsy, Interventional radiology, Breast surgery, Pathology, Breast biopsy, Prostate biopsy

As an investigator in the German PULSE-trial* Dr Peisker has already acquired know-how and familiarity with pulse biopsy in diagnosis of breast cancer.

Key Points: 
  • As an investigator in the German PULSE-trial* Dr Peisker has already acquired know-how and familiarity with pulse biopsy in diagnosis of breast cancer.
  • The innovative pulse biopsy system has a potential to improve clinical practice in all ultrasound guided biopsies, including vacuum biopsy," says Dr Uwe Peisker from Hermann-Josef-Hospital in Erkelenz.
  • NeoDynamics' team in Germany has successfully introduced the pulse biopsy system NeoNavia to physicians at selected clinics, despite the difficulties to access hospitals and medical staff during the pandemic.
  • "The first commercial order of NeoNavia in Germany is an important milestone for NeoDynamics.

NeoDynamics receives first German order of pulse biopsy system NeoNavia

Retrieved on: 
Venerdì, Luglio 9, 2021
Clinical medicine, Medicine, Medical specialties, Biopsy, Interventional radiology, Breast surgery, Pathology, Breast biopsy, Prostate biopsy

As an investigator in the German PULSE-trial* Dr Peisker has already acquired know-how and familiarity with pulse biopsy in diagnosis of breast cancer.

Key Points: 
  • As an investigator in the German PULSE-trial* Dr Peisker has already acquired know-how and familiarity with pulse biopsy in diagnosis of breast cancer.
  • The innovative pulse biopsy system has a potential to improve clinical practice in all ultrasound guided biopsies, including vacuum biopsy," says Dr Uwe Peisker from Hermann-Josef-Hospital in Erkelenz.
  • NeoDynamics' team in Germany has successfully introduced the pulse biopsy system NeoNavia to physicians at selected clinics, despite the difficulties to access hospitals and medical staff during the pandemic.
  • "The first commercial order of NeoNavia in Germany is an important milestone for NeoDynamics.

Global Prostate Cancer Diagnostics Market Report 2021-2027: Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy - ResearchAndMarkets.com

Retrieved on: 
Giovedì, Giugno 17, 2021
Health, Oncology, Anatomy, Branches of biology, Prostate cancer, Clinical medicine, Histopathology, Tumor markers, PCA3, Prostate, Cancer, Prostate biopsy, Prostate cancer screening

The "Prostate Cancer Diagnostics Market Global Forecast By Type (Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Prostate Cancer Diagnostics Market Global Forecast By Type (Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Global Prostate Cancer Diagnostics Market will be US$ 7.5 Billion by 2027, from US$ 1.6 Billion in 2020
    Global Prostate Cancer Diagnostics Industry is expected to grow with a double-digit staggering CAGR of 24.69% during 2020-2027.
  • Cancer, especially prostate cancer, has impacted more to men than women as their percentage was much lesser than men.
  • Our study investigated that, Prostate cancer is the 2nd most common cancer in men across developed countries to date.

Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier

Retrieved on: 
Martedì, Maggio 25, 2021
Oncology, Health, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Medical specialties, Anatomy, Clinical medicine, Prostate cancer, Histopathology, Prostate biopsy, Prostate, Biopsy, Oncology, Decipher Prostate, Veracyte, DECIPHER PROSTATE, VERACYTE

(Nasdaq: VCYT) today announced new data from two studies that further demonstrate the Decipher Prostate Genomic Classifier (GC) provides prognostic information that can help physicians tailor treatment decisions for men with prostate cancer.

Key Points: 
  • (Nasdaq: VCYT) today announced new data from two studies that further demonstrate the Decipher Prostate Genomic Classifier (GC) provides prognostic information that can help physicians tailor treatment decisions for men with prostate cancer.
  • The findings will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held virtually June 4-8, 2021.
  • Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) is a 22-gene, microarray-based genomic test intended to help inform treatment decisions for men with localized prostate cancer at initial diagnosis and after surgical removal of the prostate.
  • Veracyte, Afirma, Percepta, Envisia, Prosigna, "Know by Design" and the Veracyte, Afirma, Percepta, Envisia and Prosigna logos are registered trademarks of Veracyte in the U.S. and selected countries.

Quibim Receives FDA 510(k) Clearance for qp-Prostate New AI Solution for Prostate MRI Analysis

Retrieved on: 
Giovedì, Marzo 4, 2021
Anatomy, Branches of biology, Medical physics, Medical imaging, Histopathology, Radiology, Prostate cancer, Prostate, Magnetic resonance imaging, Prostate biopsy, Phantom structure

Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail.

Key Points: 
  • Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail.
  • "MRI is the perfect modality for prostate evaluation, however, only 5% of radiologists are trained to interpret prostate MRI data," explained Prof. Luis Mart-Bonmat, Quibim co-founder.
  • The software runs on a standard "off-the-shelf" workstation and can be used to perform image viewing, processing and analysis of prostate MR images.
  • Quibim, a company with its headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis.